Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 699 shares of Varian Medical Systems stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $126.47, for a total value of $88,402.53. Following the transaction, the executive vice president now directly owns 27,361 shares in the company, valued at $3,460,345.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Varian Medical Systems, Inc. (NYSE VAR) opened at $125.49 on Wednesday. Varian Medical Systems, Inc. has a 1 year low of $87.49 and a 1 year high of $130.29. The firm has a market capitalization of $11,480.00, a price-to-earnings ratio of 34.38, a P/E/G ratio of 3.67 and a beta of 0.85.

How to Become a New Pot Stock Millionaire

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. The business had revenue of $678.50 million during the quarter, compared to analyst estimates of $633.96 million. During the same quarter last year, the company posted $1.09 EPS. Varian Medical Systems’s revenue for the quarter was up 12.8% on a year-over-year basis. equities research analysts expect that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current year.

Several large investors have recently added to or reduced their stakes in VAR. First Eagle Investment Management LLC boosted its position in Varian Medical Systems by 2.1% during the 3rd quarter. First Eagle Investment Management LLC now owns 4,778,741 shares of the medical equipment provider’s stock worth $478,161,000 after acquiring an additional 99,270 shares during the period. APG Asset Management N.V. boosted its position in Varian Medical Systems by 6.7% during the 4th quarter. APG Asset Management N.V. now owns 1,780,901 shares of the medical equipment provider’s stock worth $164,846,000 after acquiring an additional 111,482 shares during the period. Wells Fargo & Company MN boosted its position in Varian Medical Systems by 7.5% during the 4th quarter. Wells Fargo & Company MN now owns 1,205,836 shares of the medical equipment provider’s stock worth $134,029,000 after acquiring an additional 83,772 shares during the period. Geode Capital Management LLC boosted its position in Varian Medical Systems by 4.2% during the 4th quarter. Geode Capital Management LLC now owns 1,186,042 shares of the medical equipment provider’s stock worth $131,599,000 after acquiring an additional 47,590 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in Varian Medical Systems by 15.9% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,134,054 shares of the medical equipment provider’s stock worth $113,474,000 after acquiring an additional 155,954 shares during the period. Institutional investors and hedge funds own 99.22% of the company’s stock.

A number of research analysts recently issued reports on VAR shares. TheStreet lowered Varian Medical Systems from a “b+” rating to a “c” rating in a report on Monday, February 12th. Evercore ISI started coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 target price on the stock. Zacks Investment Research raised Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Monday, January 29th. ValuEngine raised Varian Medical Systems from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Finally, JPMorgan Chase & Co. increased their price target on Varian Medical Systems from $88.00 to $105.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $111.80.

TRADEMARK VIOLATION NOTICE: This news story was reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.dailypolitical.com/2018/03/14/insider-selling-varian-medical-systems-inc-var-evp-sells-699-shares-of-stock.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.